July 2015 | DelveInsight Business Research Skip to main content
delveinsight blog
  • ABOUT
    • About Us
    • Our Leadership
    • Our Clients
  • CAPABILITIES & SOLUTIONS
    • Reports
    • Competitive Intelligence
    • Case Study
  • CONSULTING SERVICE
  • REPORT STORE
  • MEDIA
    • Blog
    • Press Releases
    • White Papers / Newsletter
    • Events
  • CAREER
  • CONTACT US
  • Report Store
Healthcare blog

Month: July 2015

Jul 30 “Endometrial Cancer – Pipeline Insights, 2015”- A DelveInsight’s Report

“Endometrial Cancer – Pipeline Insights, 2015”- A DelveInsight’s Report

Jul 30, 2015 DelveInsight Leave a comment

DelveInsight, the leading market research and consulting company has added a new report “Endometrial Cancer – Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight…

Read More
Jul 30 PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2015 – A DelveInsight Report

PD-1 and PD-L1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2015 – A DelveInsight Report

Jul 30, 2015 DelveInsight Leave a comment

DelveInsight has made strong presence in Oncology market with 100+ Reports on Oncology based Indications & Mechanism of Action (MOA).DelveInsight Report, PD-1 and PD-L 1 inhibitors – Competitive Landscape,…

Read More
Jul 30 Systemic Juvenile Idiopathic Arthritis -Pipeline Insights, 2015

Systemic Juvenile Idiopathic Arthritis -Pipeline Insights, 2015

Jul 30, 2015 DelveInsight Leave a comment

Juvenile idiopathic arthritis (JIA) Juvenile idiopathic arthritis (JIA) affects children who are less than 16 years old, commonly occurs in children from the ages of 7…

Read More
Jul 29 Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015

Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015

Jul 29, 2015Mar 30, 2019 DelveInsight Leave a comment

DelveInsight, the leading market research and consulting company has added new report  Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015 to its portfolio. With this launch DelveInsight…

Read More
Jul 24 Oral Mucositis-Pipeline Insights, 2015- A DelveInsight Report

Oral Mucositis-Pipeline Insights, 2015- A DelveInsight Report

Jul 24, 2015 DelveInsight Leave a comment

In current scenario chemotherapies and radiations are prominently used to cure cancer which results in adverse effects. Oral Mucositis is one such adverse effect that results in…

Read More
Jul 23 Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) – Competitive Landscape, Pipeline and Market Analysis, 2015

Cytotoxic T lymphocyte associated antigen-4 (CTLA-4) – Competitive Landscape, Pipeline and Market Analysis, 2015

Jul 23, 2015 DelveInsight Leave a comment

Cancer is one of the pioneer causes of obliteration. Although a lot of therapies are being developed in this area but still there is a high…

Read More
Jul 16 DelveInsight’s Oncology based Reports, 2015

DelveInsight’s Oncology based Reports, 2015

Jul 16, 2015 DelveInsight Leave a comment

DelveInsight, the leading market research and consulting company has added Oncology based Reports to its portfolio. With this launch DelveInsight now has 100+ Oncology based Reports….

Read More
Jul 7 DelveInsight’s Indication Active Pharmaceutical Ingredient (API) Reports– 2015

DelveInsight’s Indication Active Pharmaceutical Ingredient (API) Reports– 2015

Jul 7, 2015 DelveInsight Leave a comment

DelveInsight expertise over 400+ Indication Active Pharmaceutical Ingredient (API) Reports DelveInsight, leading Market Research and Business Consulting firm has an expertise in providing business solutions to…

Read More

Recent Posts

  • Fragile X Syndrome Market
  • Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition
  • Gaucher disease Market: Pipeline and Future Trends
  • Acquisition of ArQule; Synthorx; and Zentalis nabs a raise
  • Are Rare diseases truly Rare?

Browse by Category

  • Anti-coagulants (8)
  • API Business Opportunity (5)
  • Articles (285)
  • Atrial Fibrillation (6)
  • Business Consultant (449)
    • Pharma Consultant (430)
  • Chimeric Antigen Receptor (CAR) T-cell Therapy (7)
  • CNS Indications (1)
  • CVS Indications (4)
  • DelveInsight's Drug Report (154)
  • DelveInsight's Indication Pipeline Reports (69)
  • DelveInsight's Oncology based Reports (47)
  • Gene Therapy Products (31)
  • Infographics (40)
  • new therapeutic target (5)
  • Newsletter (2)
  • Notizia (156)
  • Oncology based Indications (11)
  • Orphan market (5)
  • PD-1 and PD-L1 inhibitors (5)
  • Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors (1)
  • Pulmonary arterial hypertension (1)
  • Rising of Orphan Drug Development (3)
  • Snippets (128)
  • Specialized Reports (15)
  • The Business Cocktail (140)
  • Uncategorized (61)
  • Venous Thromboembolism (3)

Archives

  • December 2019 (12)
  • November 2019 (24)
  • October 2019 (27)
  • September 2019 (23)
  • August 2019 (22)
  • July 2019 (25)
  • June 2019 (30)
  • May 2019 (29)
  • April 2019 (29)
  • March 2019 (27)
  • February 2019 (20)
  • January 2019 (18)
  • December 2018 (19)
  • November 2018 (26)
  • October 2018 (21)
  • September 2018 (20)
  • August 2018 (26)
  • July 2018 (13)
  • June 2018 (5)
  • May 2018 (8)
  • April 2018 (6)
  • March 2018 (14)
  • February 2018 (11)
  • January 2018 (15)
  • December 2017 (8)
  • November 2017 (13)
  • October 2017 (8)
  • September 2017 (14)
  • August 2017 (13)
  • July 2017 (9)
  • June 2017 (14)
  • May 2017 (20)
  • April 2017 (19)
  • March 2017 (24)
  • February 2017 (21)
  • January 2017 (23)
  • December 2016 (22)
  • November 2016 (23)
  • October 2016 (17)
  • September 2016 (21)
  • August 2016 (17)
  • May 2016 (4)
  • March 2016 (8)
  • February 2016 (3)
  • January 2016 (7)
  • November 2015 (1)
  • October 2015 (1)
  • September 2015 (2)
  • August 2015 (2)
  • July 2015 (8)
  • June 2015 (4)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (6)
  • February 2015 (2)
  • January 2015 (5)
  • December 2014 (17)
  • November 2014 (2)
  • September 2014 (1)
  • August 2014 (7)
  • July 2014 (7)
delveinsight


Quick Links

  • About
  • Capabilities & Solutions
  • Report Store
  • Media
  • Career
  • Contact Us

Contact Us

Phone

India: +91-11-45689769, +91-9650213330

Email

info@delveinsight.com

Address

New Delhi-110075, India

Address

304 S. Jones Blvd #2432, Las Vegas NV 89107

Phone

Outside India: +1(919)321-6187

Latest Tweets

Tweets by @DelveInsight

Copyright © 2019 Delveinsight.

  • Sitemap
  • Terms & Conditions
  • Privacy policy